Articles published by Merck & Co., Inc.
![](https://mms.businesswire.com/media/20221022005008/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20221018005485/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20221007005569/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck Recognized on Fortune’s 2022 Change the World List for Expanding Access to HPV Vaccines
October 10, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20221010005227/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20221006006068/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20220929005889/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
U.S. Court of Appeals for the Federal Circuit Rules in Favor of Merck in Sitagliptin Dihydrogen Phosphate Patent Lawsuit
September 29, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20220929005282/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20220927005283/en/439684/5/Merck_Animal_Health_Logo.jpg)
Merck Animal Health Completes Minority Investment in LeeO Precision Farming
September 27, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20220927005190/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20220922005501/en/439684/5/Merck_Animal_Health_Logo.jpg)
Merck Animal Health to Acquire Vence
September 22, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20220922005300/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20220920005576/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20220915006126/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck Receives Positive CHMP Opinion for VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) in Infants and Children
September 16, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20220911005044/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20220909005545/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20220909005050/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20220906005270/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20220830005845/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck Reports Strong Progress in ESG Focus Areas
August 30, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20220829005222/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20220825005257/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20220823005228/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck Receives Fast Track Designation from the U.S. FDA for MK-2060, an Investigational Anticoagulant Therapy
August 23, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20220816005290/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20220816005245/en/1544764/5/Orna_Logo_TM_Full_Color_RGB_HIGH.jpg)
Merck and Orna Therapeutics Collaborate to Advance Orna’s Next Generation of RNA Technology
August 16, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20220804005318/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20220803005211/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20220803005334/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20220728005295/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck Announces Second-Quarter 2022 Financial Results
July 28, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20220726005947/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck Announces Fourth-Quarter 2022 Dividend
July 26, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20220720005181/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.